Related Experiment Video

Updated: May 19, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

TGF beta signaling and its role in glioma pathogenesis

Bozena Kaminska1, Marta Kocyk, Magdalena Kijewska

  • 1Laboratory of Transcription Regulation, Department of Cell Biology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur St., PL 02-093, Warsaw, Poland. bozenakk@nencki.gov.pl

Advances in Experimental Medicine and Biology
|August 11, 2012
PubMed

Insights

Transforming growth factor beta (TGF-β) signaling impacts glioma cell behavior and malignancy. Inhibiting TGF-β shows promise for novel glioma therapeutics by reducing tumor growth and invasion.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor beta (TGF-β) signaling regulates crucial cellular processes like proliferation, differentiation, and apoptosis.
  • This pathway involves receptor-mediated activation of Smad proteins (Smad2/3, Smad4) and other kinases (TAK1), influencing gene transcription.
  • Dysregulation of TGF-β signaling, particularly increased TGF-β1-3 expression, is linked to higher glioma malignancy.

Purpose of the Study:

  • To elucidate the role of TGF-β signaling in glioma pathogenesis.
  • To explore the potential of TGF-β inhibitors as anti-glioma therapeutics.

Main Methods:

  • Analysis of TGF-β signaling pathways, including Smad and TAK1 activation.
  • Investigating the correlation between TGF-β expression levels and glioma grade.
  • Evaluating the effects of TGF-β pathway modulation on glioma cell behavior and tumor growth in preclinical models.

Main Results:

  • TGF-β signaling promotes glioma growth, self-renewal of glioma-initiating stem cells, and suppresses anti-tumor immunity.
  • TGF-β1 and TGF-β2 stimulate factors (VEGF, PAI, MMPs) involved in angiogenesis and extracellular matrix degradation.
  • Inhibitors of TGF-β signaling demonstrated reduced glioma viability and invasion in animal models.

Conclusions:

  • TGF-β signaling is a key driver of glioma progression and malignancy.
  • Targeting TGF-β signaling represents a promising therapeutic strategy for human gliomas.

More Related Videos

Translational Orthotopic Models of Glioblastoma Multiforme07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: